Falcon Therapeutics, Inc.

Chapel Hill, NC · Founded 2015 · CIK 0001709056 · Biotech · Defunct

Autologous induced neural stem cell (iNSC) carriers engineered from patient skin fibroblasts via SOX2-driven transdifferentiation, modified to deliver chemotoxic agents to glioblastoma tumors

Grants
$2.5M
3 awards
Sector median: 1
Raised
$700K
1 Form D · Jun 2017
111 months since last filing
Contracts
—
No federal contracts on record
Patents
4
0 granted · 4 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Personalized Neural Stem Cell Therapy for Cancer$225,000
Private capital raisedForm D · SEC$700,000
Federal grantDepartment of Health and Human Services · Phase II · Personalized Neural Stem Cell Therapy for Cancer$1,493,077
Federal grantDepartment of Health and Human Services · Phase II · Personalized Neural Stem Cell Therapy for Cancer$776,434
Federal grant · SBIR/STTRForm D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2152KANNALIFE SCIENCES, INC.—$1.5M
2153QRKANSWER LLC——
2154Valeo Pharma Inc.—$787K
2155Falcon Therapeutics, Inc.—$700K
2156Mindset Pharma Inc.—$694K
2157Bitterroot Bio——
2158ASL Analytical, Inc.—$2.4M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Matthew EwendDirector
  • Karen GirouxDirector · Executive Officer
  • Shawn HingtgenDirector
  • Anna SealDirector · Executive Officer

Patents

USPTO · 0 granted of 4
  • Itdc Compositions And Methods For Use In Therapeutic Methodsapplication
  • Engineered Stem Cell Constructs And Uses Thereofapplication
  • Transdifferentiated Cell Compositions And Methods For Use In Therapeutic Methodsapplication
  • Engineered Stem Cell Constructs And Uses Thereofapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.